Overview

Following the success of last year's event, Radcliffe Cardiology is proud to present the second edition of our one-day event, Advancements in Obesity Management (AOM). 

Taking place on Wednesday 11 June 2025, this event delves into the intricate connections between obesity and cardio-renal-metabolic (CVRM) diseases, highlighting the shared pathways that contribute to these conditions.

Join us for this live event to enhance your understanding of evidence-based, personalised treatment strategies to reduce the impact of obesity. Led by Course Directors Dr Harold Bays (Louisville Metabolic and Atherosclerosis Research Centre, US) and Prof Naveed Sattar (University of Glasgow, UK), the programme brings together a panel of distinguished global experts in the field of obesity and cardiovascular disease.

Register today to stay at the forefront of advancements in practical obesity therapy. We look forward to welcoming you back to this insightful event.

Event starts in:

Programme

3:00 PM - 3:05 PM (CEST)
Day Welcome
Event Welcome

Welcome and Introduction

Course Directors: Harold Bays, Louisville, US & Naveed Sattar, Glasgow, UK



3:05 PM - 4:00 PM (CEST)
Plenary Session
Session 1: Essential Obesity-Related Health Risks: The Scale of the Problem

In this session, we explore the true impact of obesity as a chronic disease, uncovering the complex health risks linked to obesity and how it fuels multiple comorbidities. Gain a deeper understanding of the challenges patients face, confront stigma and learn practical ways to improve care and access to treatment.

Chair: Naveed Sattar, Glasgow, UK

Panel: Helen Parretti, Beccles, UK; Liesbeth van Rossum, Rotterdam, NL

  • Introduction to a Patient Living With Obesity – Helen Parretti

  • Obesity in Practice: Understanding Patient Realities – Liesbeth van Rossum

  • Obesity’s Ripple Effect: How It Fuels Comorbidities – Naveed Sattar

  • Putting the Care Into Obesity Management – All Faculty

  • Audience Q&A

 



4:00 PM - 5:00 PM (CEST)
Plenary Session
Session 2: Essential Outcomes Data Driving Therapeutic Interventions

In this session, discover the impact of nutrition, physical activity and behaviour modification on obesity management. Explore the latest evidence behind surgical and pharmacological treatments and their impact on MACE, and learn when and how to refer patients, balancing efficacy and safety, to achieve the best long-term outcomes.

Chair: Harold Bays, Louisville, US

Panel: Lydia Alexander, San Mateo, US; Alexander Miras, Derry, UK; Liesbeth van Rossum, Rotterdam, NL

  • The Power Trio: Nutrition, Movement and Mindset in Obesity Management – Lydia Alexander

  • Balancing Efficacy, Safety and Long-term Impact of Procedural Approaches – Alexander Miras

  • Pharmacological Advances – Latest Trial Data and Impact on Health Outcomes – Harold Bays

  • Global Perspectives – Treatment Goals, Guidelines and When to Recommend Pharmacotherapy or Bariatric Procedures – All Faculty

 



5:00 PM - 5:30 PM (CEST)
Break
Break

Featuring key interviews:

  • ECR Guest Editor Prof Chim Lang on his upcoming collection: Obesity in Focus: Implications for Heart Failure, Kidney Disease, and Pharmacology

  • CFR Article Spotlight: Dr Mohammed El-Sheikh on his new publication: Associations of Obesity and Prognostic Nutritional Index on 1-Year Mortality in Patients with Acute Heart Failure.

  • AER Article Spotlight: Dr Kyaw Zaw Win on his new publication: The Management of Obesity Before Catheter Ablation of AF: The Missing Piece?

 



5:30 PM - 6:30 PM (CEST)
Plenary Session
Session 3: Essentials of Patient Management: Real-World Implementation

In this session, learn how to approach obesity as a disease with sensitivity, moving beyond weight loss to support meaningful patient conversations. You’ll discover strategies to improve adherence to treatments, manage post-intervention care and work effectively within multidisciplinary teams for comprehensive obesity management. 

Chair: Naveed Sattar, Glasgow, UK

Panel: Lydia Alexander, San Mateo, US; Harold Bays, Louisville, US; Carel le Roux, Dublin, IE

  • Obesity as a Disease: Shifting the Conversation Beyond Weight Loss – Naveed Sattar

  • Optimising Retention and Adherence of Pharmacological Therapies – Lydia Alexander & Harold Bays

  • Post-bariatric Surgery Patient Care and Management Carel le Roux

  • Working as an MDT: The Referral Process and Its Importance in Comprehensive Obesity Care – Panel Discussion and Audience Q&A – All Faculty

 



6:30 PM - 7:25 PM (CEST)
Plenary Session
Session 4: The Essential Way Forward

In this final session, we revisit the earlier patient case to identify gaps in current obesity therapies and explore upcoming clinical trials shaping future treatment options. You’ll gain insight into innovative approaches and technologies set to transform obesity care.

Chair: Harold Bays, Louisville, US

Panel: Liesbeth van Rossum, Rotterdam, NL; Carel le Roux, Dublin, IE

  • Patient Case in Focus – Current Therapy and Gaps in Care – Liesbeth van Rossum

  • Upcoming Clinical Trials: 12-month Countdown – Harold Bays

  • The Future: What’s Next in Obesity Treatment – Carel le Roux

  • Panel Discussion and Audience Q&A – All Faculty

 



7:25 PM - 7:30 PM (CEST)
Day Summary
Event Close

Closing Remarks

 




Course Directors

Harold Bays

Harold Bays
Course Director
Louisville Metabolic and Atherosclerosis Research Center, Louisville, US

more info

Naveed Sattar

Naveed Sattar
Course Director
University of Glasgow, Glasgow, UK

more info

Faculty

Lydia Alexander
Lydia Alexander

Enara Health, San Mateo, US

Mohammed El-Sheikh
Mohammed El-Sheikh

Copenhagen University Hospital, Hvidovre, DK

Chim Lang
Chim Lang

University of Dundee, Dundee, UK

Carel le Roux
Carel le Roux

University College Dublin, Dublin, IE

Alexander Miras
Alexander Miras

Ulster University, Derry, UK

Helen Parretti
Helen Parretti

Beccles Medical Centre, Beccles, UK

Liesbeth van Rossum
Liesbeth van Rossum

Erasmus University, Rotterdam, NL

Kyaw Zaw Win
Kyaw Zaw Win

University of Birmingham, Birmingham, UK

Learning Objectives

  • Participants will be able to discuss their role in referral pathways and practical patient management
  • Apply current treatment methodologies to reduce the impact of obesity on cardio-renal-metabolic diseases and non-metabolic obesity related diseases utilising the multidisciplinary team
  • Interpret and discuss clinical trial data for emerging obesity therapies and their wider metabolic impact beyond weight loss
  • Apply evidence-based treatment methodologies to reduce the impact of obesity through the multidisciplinary team (MDT) and a personalised care approach

Target Audience

  • Cardiologists
  • Diabetologists
  • Endocrinologists
  • Neurologists
  • Nurses
  • Obesity Specialists
  • Primary Care Physicians

If you’re interested in becoming an educational partner at AOM, please contact sales@radcliffe-group.com

Official Journal

European Cardiology Review (ECR) is an international, English-language, peer-reviewed journal that publishes articles continuously on ECRjournal.com. It aims to assist time-pressured physicians to stay abreast of key advances and opinions in the area of cardiovascular disease.

The journal comprises balanced and comprehensive review articles written by leading authorities. The journal provides updates on a range of salient issues to support physicians in developing their knowledge and effectiveness in day-to-day clinical practice.

The journal endeavours to support the continuous medical education of specialist and general cardiologists and disseminate knowledge of the field to the wider cardiovascular community.

View the 2024 volume of ECR.

About Radcliffe CVRM

Radcliffe CVRM is dedicated to supporting learning among cardiologists, nephrologists, diabetologists, endocrinologists, obesity specialists and primary care physicians for better outcomes in patients with cardiovascular, renal and metabolic conditions.

The Radcliffe CVRM platform delivers expert-driven, high-quality content across cardiovascular, renal and metabolic health. It emphasises the growing burden of obesity and its associated conditions, including metabolic dysfunction-associated fatty liver disease (MAFLD). Discover insightful articles, dynamic discussions and the latest research summaries from key conferences, keeping you at the forefront of CVRM care.

Join a Leading Community in CVRM

  • Connect with a global community dedicated to advancing cardiovascular, renal and metabolic therapy.  Here’s what you’ll find on the platform:

  • Virtual Events and Expert Insights: Engage with leading specialists through interactive events, practical tips and live case presentations that bridge cardiovascular, renal and metabolic care.

  • Latest Conference Highlights: Access concise summaries of pivotal data from major CVRM, nephrology, endocrinology and obesity disease conferences.

  • Innovations in CVRM: Stay updated on the latest technologies, treatment strategies and advancements that are shaping the future of cardiovascular, renal and metabolic care.

For more information on Radcliffe CVRM, please visit www.radcliffecvrm.com